NSCLC ADENOCARCINOMA

Clinical trials for NSCLC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new NSCLC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for NSCLC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

Scientists test direct tumor injection to boost cancer fight

Disease control Ongoing

This early-stage study is testing the safety and feasibility of new ways to deliver an immune-boosting drug called IMP321 to people with advanced solid tumors. Researchers are trying methods like injecting the drug directly into tumors or into the abdominal cavity, and combining …

Matched conditions: NSCLC ADENOCARCINOMA

Phase: PHASE1 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

NSCLC ADENOCARCINOMA

Get alerted when new NSCLC ADENOCARCINOMA trials appear

Scientists test direct tumor injection to boost cancer fight